DLH Holdings Corp. Stock News

A legal tool known as government patent use lets HHS control remdesivir manufacturing and distribution by compensating Gilead for the use of its patents.

Guards at quarantine hotels are still misusing or not using personal protection equipment, as the government investigates failures in its own operation linked to Victoria's second COVID-19 spike.

All North Carolinians living and working in nursing homes will soon receive a one-time coronavirus test, the state announced Tuesday. Mandy Cohen, the

Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19.

Public health experts on Wednesday criticised the US for securing for itself a large supply of the only drug licensed so far to treat Covid-19.

The state's Chief Health Officer says it wasn't his decision to use private security firms to guard Melbourne's quarantine hotels, as Victoria recorded 77 new COVID-19 cases.

Novartis agrees to $642mn US settlement over kickbacks

Several of Trump's top aides have begun to worry about his chances to win re-election, fears borne out by a steady stream of public polls showing Trump trailing his election rival, Joe Biden, by doubl

The Department of Health and Human Services said it had secured 500,000 treatments of the drug through September, representing 100% of Gilead's July production capacity and 90% of its capacity in Augu

Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19. The U.S. government

The letter, which includes signatures from 150 community members, many of whom are Brunswick High School graduates, states the school department must determine the scope and the breadth of sexual viol

As the State Government faces increased scrutiny over its handling of hotel quarantine, Minister Lisa Neville says Victorians have been let down because the risk posed by returned travellers was not t

Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19.

Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19.

(Reuters Breakingviews) - Corona Capital is a daily column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.